Quality of life evidence for patients with Alzheimer’s disease: use of existing quality of life evidence from the ADENA trials to estimate the utility impact of Exelon®

This paper utilises the Mini-Mental State Examination (MMSE) score of patients with Alzheimer’s disease to establish a relationship between disease progression and quality of life measures, and the author also compares his results to findings from the literature review about Alzheimer’s patient utility.

MoreLess

Year of publication:	2001
Authors:	Brazier, J
Institutions:	Volkswirtschaftliche Fakultät, Ludwig-Maximilians-Universität München
Subject:	Alzheimer's disease \| quality of life

More details

Extent:	application/pdf
Series:	MPRA Paper.
Type of publication:	Book / Working Paper
Classification:	I31 - General Welfare; Basic Needs; Quality of Life ; I19 - Health. Other
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10008876652